Table 4. Relationship between BMPRIB expression and TE neo-adjuvant chemotherapy in 32 paired specimens.
| BMPRIB score, n (%) | P value | ||
|---|---|---|---|
| Low (0-140) | High (141-200) | ||
| Total | 0.007* | ||
| Pre-neoadjuvant chemotherapy | 28 (87.5) | 4 (12.5) | |
| Post-neoadjuvant chemotherapy | 19 (59.4) | 13 (40.6) | |
| Positive pathological response | 0.034* | ||
| Pre-neoadjuvant chemotherapy | 16 (80.0) | 4 (20.0) | |
| Post-neoadjuvant chemotherapy | 10 (50.0) | 10 (50.0) | |
| Negative pathological response | 0.083 | ||
| Pre-neoadjuvant chemotherapy | 12 (100.0) | 0 (0.0) | |
| Post-neoadjuvant chemotherapy | 9 (75.0) | 3 (25.0) | |
Statistical analysis was used Wilcoxon matched pairs signed rank test.